Peter Lee, MD
Surgery · Tucson, AZNPI 1891939708
Payments from drug & device makers
Across 57 payments — averaging $233.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$12K
- Johnson & Johnson$176
- Coloplast$136
- Integra Lifesciences Corporation$99
- Solventum Corporation$58
- Blueprint Medicines Corporation$35
- plus $320 from 14 others
What the payments were for
- Travel & lodging$3,19624%
- Food & beverage$1,60012%
- Education$8,50064%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 31 | $12,488 |
| Johnson & Johnson | 4 | $176 |
| Coloplast | 1 | $136 |
| Integra Lifesciences Corporation | 1 | $99 |
| Solventum Corporation | 2 | $58 |
| Blueprint Medicines Corporation | 2 | $35 |
| Pfizer | 2 | $34 |
| THD America, Inc. | 2 | $33 |
| Novartis | 1 | $28 |
| Beone Medicines USA, Inc. | 1 | $28 |
| Beigene USA, Inc. | 1 | $28 |
| Vertex | 1 | $25 |
| Dentsply Sirona Inc | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Sanofi | 1 | $22 |
| Baxter Healthcare | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Seagen Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Baudax Bio Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$8,500
- Da Vinci Surgical System$3,381
- SenSura Mio$136
- Echelon Powered Circular$120
How this compares
$13,312 in reported general payments places this provider in the 80th percentile of 614 surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 11 | $729 |
| Neomycin Sulfate | 40 | $221 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $173 |
| Ondansetron OdtOndansetron | 30 | $144 |
| Metronidazole | 41 | $84 |
| Oxycodone Hcl | 20 | $69 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other surgery in Tucson
- Rifat LatifiTucson$355K
- Sarah DucharmeTucson$150K
- Katie ArtzTucson$103K
- Jenelle OlsonTucson$72K
- Stuart MelcerTucson$71K
- Patrick ChiassonTucson$71K
- Andrew NejadTucson$57K
- Tiffany SonTucson$47K
- Michael ProbstfeldTucson$46K
- Guillermo Higa SansoneTucson$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.